Send to

Choose Destination
Oncotarget. 2018 Jun 12;9(45):27895-27906. doi: 10.18632/oncotarget.25602. eCollection 2018 Jun 12.

Breast cancer recurrence after reconstruction: know thine enemy.

Author information

Department of Plastic and Hand Surgery, Technical University of Munich, Munich 81675, Germany.
Section of Plastic and Reconstructive Surgery, Kepler University Hospital Linz, Linz 4020, Austria.


Breast reconstruction proceeding cancer treatment carries risk, regardless of the type of surgery. From fat grafting, to flap placement, to implants, there is no guarantee that reconstruction will not stimulate breast cancer recurrence. Research in this field is clearly divided into two parts: scientific interventional studies and clinical retrospective evidence. The reconstructive procedure offers hypoxia, a wound microenvironment, bacterial load, adipose derived stem cells; agents shown experimentally to cause increased cancer cell activity. This is compelling scientific evidence which serves to bring uncertainty and fear to the reconstructive procedure. In the absence of clinical evidence, this laboratory literature landscape is now informing surgical choices. Curiously, clinical studies have not shown a clear link between breast cancer recurrence and reconstructive surgery. Where does that leave us? This review aims to analyze the science and the surgery, thereby understanding the oncological fear which accompanies breast cancer reconstruction.


breast cancer recurrence; breast implants; fat grafting; flaps; reconstructive surgery

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

Publication type

Publication type

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center